Conagra Brands is to affix labels on some of its Healthy Choice products in the new year in a bid to catch the eye of users ...

The U.S. obesity rate declined for the first time in a decade last year, coinciding with the rise of GLP-1 weight-loss ...

Over half of American adults are eligible for semaglutide, but insurance and other barriers make it hard for people to access ...

New research found that some anti-obesity medications such as Wegovy and Zepbound may prompt people to drink less. These ...

Popular GLP-1 medications like semaglutide in Ozempic and Wegovy help people lose weight, but what should patients know about ...

Mounjaro is a newer medication that targets two key hormones, GLP-1 and GIP, both of which play roles ... It’s recommended ...

Struggles with obesity are a longstanding issue for millions of Americans and thousands of Iowans, but recent advancements in ...

A few years ago, West Virginia, which has the highest obesity rate in the nation, quietly began a small and unusual pilot ...

With the Biden administration pushing for Medicare, Medicaid coverage of GLP-1s, analysts disagree on whether it will ...

Taking a break from weight-loss medication over the holidays might seem like a small decision, but it can have lasting ...

People struggling with their body weight experienced joy when new, more effective prescription drug options became the rage ...

Studies suggest that semaglutide reduces heart attack and stroke and may curb addiction and more. Scientists reflect on the future of GLP-1 drugs beyond weight loss.